Y-mabs therapeutics added to the nasdaq biotechnology index

New york, dec. 13, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced it will be added to the nasdaq biotechnology index (nasdaq: nbi), effective prior to the market open on monday, december 18, 2023.
YMAB Ratings Summary
YMAB Quant Ranking